Dr Kirtiman Srivastava

Postdoctoral Researcher
Research Focus

My translational cancer research in pancreatic ductal adenocarcinomas (PDAC) involves; (a) Identification and quantification of PDAC biomarkers in patient urine samples in order to predict PDAC onset much earlier in the disease progression; and (b) Conducting basic science research to study the transformation of normal pancreatic cells to PanINs and PDAC in relation to the expression of S100PBP.

Supervisor:
Dr Tatjana Crnogorac-Jurcevic